From a biochemical pharmacy viewpoint, Relafen 750, containing naproxen, embodies a fascinating case study in medication action. Its chief mechanism involves blocking cyclooxygenase (COX) enzymes, specifically COX-2, which results in reduced production of prostaglandins . This specific inhibition alleviates tenderness and pain associated with condi